Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | MMP3 | P08254 | 3/20 | 0.42 |
| ▸ | MMP2 | P08253 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | HRH2 | P25021 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP13 | P45452 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21376945 | 0.90 | RAB9A (0.47) | RAB9AALDH1A1MAPTHDAC1HDAC2 | |
| SCHEMBL25699829 | 0.80 | TSHR (0.51) | ALDH1A1HTTGAAHRH2HRH1 | |
| SCHEMBL13767448 | 0.80 | RARB (0.59) | RAB9AALDH1A1MAPTHDAC1HDAC2 | |
| SCHEMBL14562517 | 0.80 | THRB (0.49) | RAB9AALDH1A1MAPTHDAC1HDAC2 | |
| SCHEMBL6738597 | 0.76 | GSK3B (0.63) | RAB9AALDH1A1MAPTHTTGSK3B | |
| SCHEMBL19789608 | 0.76 | THRB (0.44) | RAB9AALDH1A1MAPTHDAC1HDAC2 | |
| SCHEMBL13427412 | 0.76 | THRB (0.49) | RAB9AALDH1A1MAPTHDAC1HDAC2 | |
| SCHEMBL21336519 | 0.75 | RAB9A (0.51) | RAB9AALDH1A1MAPTHDAC1HDAC2 | |
| SCHEMBL6207604 | 0.74 | RAB9A (0.59) | RAB9AALDH1A1MAPTHDAC1HDAC2 | |
| SCHEMBL6210030 | 0.74 | RAB9A (0.59) | RAB9AALDH1A1MAPTHDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10023800-B2 | Composition for manufacturing optical elements with negative optical dispersion, and optically anisotropic body manufactured therefrom | LG CHEM, LTD. (KR) | 2018-07-17 | — | — | US | disclosed |
| US-10023800-B2 | Composition for manufacturing optical elements with negative optical dispersion, and optically anisotropic body manufactured therefrom | LG CHEM, LTD. (KR) | 2018-07-17 | — | — | US | disclosed |
| US-9850196-B2 | Compounds having negative optical dispersion, negative optical dispersion composition comprising the compounds, and optically anisotropic body comprising the composition | LG CHEM, LTD. (KR) | 2017-12-26 | — | — | US | disclosed |
| US-9850196-B2 | Compounds having negative optical dispersion, negative optical dispersion composition comprising the compounds, and optically anisotropic body comprising the composition | LG CHEM, LTD. (KR) | 2017-12-26 | — | — | US | disclosed |
| US-9505979-B2 | Polymerizable liquid crystal compounds, liquid crystal composition comprising the compounds, and optical film comprising the composition | LG CHEM, LTD. (KR) | 2016-11-29 | — | — | US | disclosed |
| US-9505979-B2 | Polymerizable liquid crystal compounds, liquid crystal composition comprising the compounds, and optical film comprising the composition | LG CHEM, LTD. (KR) | 2016-11-29 | — | — | US | disclosed |
| US-20160208171-A1 | COMPOSITION FOR MANUFACTURING OPTICAL ELEMENTS WITH NEGATIVE OPTICAL DISPERSION, AND OPTICALLY ANISOTROPIC BODY MANUFACTURED THEREFROM | LG CHEM, LTD. (KR) | 2016-07-21 | — | — | US | disclosed |
| US-20160208171-A1 | COMPOSITION FOR MANUFACTURING OPTICAL ELEMENTS WITH NEGATIVE OPTICAL DISPERSION, AND OPTICALLY ANISOTROPIC BODY MANUFACTURED THEREFROM | LG CHEM, LTD. (KR) | 2016-07-21 | — | — | US | disclosed |
| US-20160200662-A1 | COMPOUNDS HAVING NEGATIVE OPTICAL DISPERSION, NEGATIVE OPTICAL DISPERSION COMPOSITION COMPRISING THE COMPOUNDS, AND OPTICALLY ANISOTROPIC BODY COMPRISING THE COMPOSITION (As Amended) | LG CHEM, LTD. (KR) | 2016-07-14 | — | — | US | disclosed |
| US-20160200662-A1 | COMPOUNDS HAVING NEGATIVE OPTICAL DISPERSION, NEGATIVE OPTICAL DISPERSION COMPOSITION COMPRISING THE COMPOUNDS, AND OPTICALLY ANISOTROPIC BODY COMPRISING THE COMPOSITION (As Amended) | LG CHEM, LTD. (KR) | 2016-07-14 | — | — | US | disclosed |
| US-20160200977-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUNDS, LIQUID CRYSTAL COMPOSITION COMPRISING THE COMPOUNDS, AND OPTICAL FILM COMPRISING THE COMPOSITION (As Amended) | LG CHEM, LTD. (KR) | 2016-07-14 | — | — | US | disclosed |
| US-20160200977-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUNDS, LIQUID CRYSTAL COMPOSITION COMPRISING THE COMPOUNDS, AND OPTICAL FILM COMPRISING THE COMPOSITION (As Amended) | LG CHEM, LTD. (KR) | 2016-07-14 | — | — | US | disclosed |
| EP-3023816-A1 | COMPOSITION FOR MANUFACTURING OPTICAL DEVICE HAVING NEGATIVE OPTICAL DISPERSION AND OPTICAL ANISOTROPIC BODY MANUFACTURED THEREFROM | LG Chem, Ltd. (KR) | 2016-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160200662-A1 | COMPOUNDS HAVING NEGATIVE OPTICAL DISPERSION, NEGATIVE OPTICAL DISPERSION COMPOSITION COMPRISING THE COMPOUNDS, AND OPTICALLY ANISOTROPIC BODY COMPRISING THE COMPOSITION (As Amended) | ZW10, OCIAD2, INF2 | RAB9A 2629/4885ALDH1A1 2071/4885MAPT 260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.